Xbrane Gets Action Date As Ranibizumab Filing Accepted By FDA

Gains BsUFA Goal Date Of 21 April 2024 For Biosimilar Rival To Lucentis

 
• By Dave Wallace
  
Desk calendar showing April 2024
Xbrane has a goal date in April 2024 for its ranibizumab biosimilar • Source: Shutterstock

More from Biosimilars

More from Products